Emerging molecular targets for brain repair after stroke

Stroke Research and Treatment

Volumn , Issue , 2013, Pages

  Krupinski, Jerzy ^a,b   Slevin, Mark ^b  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; UNTRANSLATED RNA;

BRAIN ISCHEMIA; CELL DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DISEASE COURSE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; HEREDITY; HUMAN; HUMAN GENOME PROJECT; MEDICAL INFORMATION; NERVE FIBER GROWTH; NEUROPROTECTION; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; REVIEW; RNA EDITING;

EID: 84873353608     PISSN: None     EISSN: 20420056     Source Type: Journal    
DOI: 10.1155/2013/473416     Document Type: Review

References (112)

1. Carmichael S. T., Translating the frontiers of brain repair to treatments: starting not to break the rules. Neurobiology of Disease 2010 37 2 237 242 2-s2.0-72749103747 10.1016/j.nbd.2009.09.005
2. Ohab J. J., Fleming S., Blesch A., Carmichael S. T., A neurovascular niche for neurogenesis after stroke. Journal of Neuroscience 2006 26 50 13007 13016 2-s2.0-33845656103 10.1523/JNEUROSCI.4323-06.2006 (Pubitemid 44954619)
3. Giovanni S. D., Molecular targets for axon regeneration: focus on the intrinsic pathways. Expert Opinion on Therapeutic Targets 2009 13 12 1387 1398 2-s2.0-75349109284 10.1517/14728220903307517
4. Slevin M., Badimon L., Grau-Olivares M., Ramis M., Sendra J., Morrison M., Krupinski J., Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Molecular BioSystems 2010 6 3 444 450 2-s2.0-77249131209 10.1039/b916175a
5. Benowitz L. I., Carmichael S. T., Promoting axonal rewiring to improve outcome after stroke. Neurobiology of Disease 2010 37 2 259 266 2-s2.0-72749104890 10.1016/j.nbd.2009.11.009
6. Kreisel S. H., Hennerici M. G., Bäzner H., Pathophysiology of stroke rehabilitation: the natural course of clinical recovery, use-dependent plasticity and rehabilitative outcome. Cerebrovascular Diseases 2007 23 243 255 (Pubitemid 46425791)
7. Hier D. B., Mondlock J., Caplan L. R., Behavioral abnormalities after right hemisphere stroke. Neurology 1983 33 3 337 344 2-s2.0-0020695061 (Pubitemid 13155766)
8. Kauhanen M. L., Korpelainen J. T., Hiltunen P., Määttä R., Mononen H., Brusin E., Sotaniemi K. A., Myllylä V. V., Aphasia, depression, and non-verbal cognitive impairment in ischaemic stroke. Cerebrovascular Diseases 2000 10 6 455 461 2-s2.0-0033768795
9. Carmichael S. T., Cellular and molecular mechanisms of neural repair after stroke: making waves. Annals of Neurology 2006 59 5 735 742 2-s2.0-33646337394 10.1002/ana.20845 (Pubitemid 43673150)
10. Benowitz L. I., Carmichael S. T., Promoting axonal rewiring to improve outcome after stroke. Neurobiology of Disease 2010 37 2 259 266 2-s2.0-72749104890 10.1016/j.nbd.2009.11.009
11. Chen P., Goldberg D. E., Kolb B., Lanser M., Benowitz L. I., Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 9031 9036 2-s2.0-0037172979 10.1073/pnas.132076299 (Pubitemid 34693678)
12. Papadopoulos C. M., Tsai S. Y., Alsbiei T., O'Brien T. E., Schwab M. E., Kartje G. L., Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Annals of Neurology 2002 51 4 433 441 2-s2.0-0036196245 10.1002/ana.10144 (Pubitemid 34260773)
13. Raber J., Fan Y., Matsumori Y., Liu Z., Weinstein P. R., Fike J. R., Liu J., Irradiation attenuates neurogenesis and exacerbates ischemia-induced deficits. Annals of Neurology 2004 55 3 381 389 2-s2.0-1442329310 10.1002/ana.10853 (Pubitemid 38269590)
14. Krupinski J., Kaluza J., Kumar P., Wang M., Kumar S., Prognostic value of blood vessel density in ischaemic stroke. The Lancet 1993 342 8873, article 742 2-s2.0-0027327080
15. Zhang Z. G., Chopp M., Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. The Lancet Neurology 2009 8 5 491 500 2-s2.0-64349107251 10.1016/S1474-4422(09)70061-4
16. Bliss T. M., Andres R. H., Steinberg G. K., Erratum to Optimizing the success of cell transplantation therapy for stroke. Neurobiology of Disease 2010 38 3 495 2-s2.0-77952498355 10.1016/j.nbd.2010.03.001
17. Pearce W., Epigenetics: an expanding new piece of the stroke puzzle. Translational Stroke Research 2011 2 243 247
18. Botstein D., Risch N., Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genetics 2003 33 228 237 2-s2.0-0037373275 10.1038/ng1090 (Pubitemid 36278833)
19. Ng P. C., Kirkness E. F., Whole genome sequencing. Methods in Molecular Biology 2010 628 215 226
20. Lanktree M. B., Dichgans M., Hegele R. A., Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 2010 41 4 825 832 2-s2.0-77950221224 10.1161/STROKEAHA.109.570523
21. Marnellos G., High-throughput SNP analysis for genetic association studies. Current Opinion in Drug Discovery and Development 2003 6 317 321 (Pubitemid 36702303)
22. Meschia J. F., Worrall B. B., Rich S. S., Genetic susceptibility to ischemic stroke. Nature Reviews Neurology 2011 7 369 378
23. Glaser B., Genetic analysis of complex disease-a roadmap to understanding or a colossal waste of money. Pediatric Endocrinology Reviews 2010 7 3 258 265 2-s2.0-77955866132
24. Jaenisch R., Bird A., Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics 2003 33 245 254 2-s2.0-0037372003 10.1038/ng1089 (Pubitemid 36278835)
25. Hamilton J. P., Epigenetics: principles and practice. Digestive Diseases 2011 29 130 135
26. Ballestar E., An introduction to epigenetics. Advances in Experimental Medicine and Biology 2011 711 1 11
27. Felekkis K., Touvana E., Stefanou C., Deltas C., MicroRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia 2010 14 4 236 240 2-s2.0-78149404594
28. Pan Z. W., Lu Y. J., Yang B. F., MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacologica Sinica 2010 31 1 1 9 2-s2.0-74549191957 10.1038/aps.2009.175
29. Liu N., Olson E. N., MicroRNA regulatory networks in cardiovascular development. Developmental Cell 2010 18 4 510 525 2-s2.0-77951919333 10.1016/j.devcel.2010.03.010
30. Cheng Y., Zhang C., MicroRNA-21 in cardiovascular disease. Journal of Cardiovascular Translational Research 2010 3 251 255
31. Small E. M., Olson E. N., Pervasive roles of microRNAs in cardiovascular biology. Nature 2011 469 7330 336 342 2-s2.0-78751660177 10.1038/nature09783
32. Chen K. C., Wang Y. S., Hu C. Y., Chang W. C., Liao Y. C., Dai C. Y., Juo S. H. H., OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB Journal 2011 25 5 1718 1728 2-s2.0-79955654219 10.1096/fj.10-174904
33. Han M., Toli J., Abdellatif M., MicroRNAs in the cardiovascular system. Current Opinion in Cardiology 2011 26 3 181 189 2-s2.0-79955070159 10.1097/HCO.0b013e328345983d
34. Khorram O., Han G., Bagherpour R., Magee T. R., Desai M., Ross M. G., Chaudhri A. A., Toloubeydokhti T., Pearce W. J., Effect of maternal undernutrition on vascular expression of micro and messenger RNA in newborn and aging offspring. American Journal of Physiology 2010 298 5 R1366 R1374 2-s2.0-77951715540 10.1152/ajpregu.00704.2009
35. Van Solingen C., Seghers L., Bijkerk R., Duijs J. M. G. J., Roeten M. K., Van Oeveren-Rietdijk A. M., Baelde H. J., Monge M., Vos J. B., De Boer H. C., Quax P. H. A., Rabelink T. J., Van Zonneveld A. J., Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. Journal of Cellular and Molecular Medicine 2009 13 8 1577 1585 2-s2.0-70349333970 10.1111/j.1582-4934.2008.00613.x
36. Ye Y., Hu Z., Lin Y., Zhang C., Perez-Polo J. R., Downregulation of microRNA-29 by antisense inhibitors and a PPAR- γ agonist protects against myocardial ischaemia-reperfusion injury. Cardiovascular Research 2010 87 3 535 544 2-s2.0-77954766181 10.1093/cvr/cvq053
37. Nickerson J. A., Krochmalnic G., Wan K. M., Penman S., Chromatin architecture and nuclear RNA. Proceedings of the National Academy of Sciences of the United States of America 1989 86 1 177 181 2-s2.0-0345892812 (Pubitemid 19036350)
38. Rodríguez-Campos A., Azorín F., RNA is an integral component of chromatin that contributes to its structural organization. PLoS ONE 2007 2 11 2-s2.0-43149109529 10.1371/journal.pone.0001182 e1182 (Pubitemid 351638070)
39. Mattick J. S., A new paradigm for developmental biology. Journal of Experimental Biology 2007 210 9 1526 1547 2-s2.0-34249740942 10.1242/jeb.005017 (Pubitemid 46841958)
40. Yang P. K., Kuroda M. I., Noncoding RNAs and intranuclear positioning in monoallelic gene expression. Cell 2007 128 4 777 786 2-s2.0-33847032545 10.1016/j.cell.2007.01.032 (Pubitemid 46273575)
41. Ashe H. L., Monks J., Wijgerde M., Fraser P., Proudfoot N. J., Intergenic transcription and transinduction of the human β -globin locus. Genes and Development 1997 11 19 2494 2509 2-s2.0-0030826364 (Pubitemid 27438831)
42. Abarrategui I., Krangel M. S., Noncoding transcription controls downstream promoters to regulate T-cell receptor α recombination. EMBO Journal 2007 26 20 4380 4390 2-s2.0-35348927529 10.1038/sj.emboj.7601866 (Pubitemid 47587667)
43. Peng J. C., Karpen G. H., H3K9 methylation and RNA interference regulate nucleolar organization and repeated DNA stability. Nature Cell Biology 2007 9 1 25 35 2-s2.0-33845866637 10.1038/ncb1514 (Pubitemid 46024194)
44. Nowacki M., Vijayan V., Zhou Y., Schotanus K., Doak T. G., Landweber L. F., RNA-mediated epigenetic programming of a genome-rearrangement pathway. Nature 2008 451 7175 153 158 2-s2.0-38049186458 10.1038/nature06452
45. Schoeftner S., Blasco M. A., Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nature Cell Biology 2008 10 2 228 236 2-s2.0-38849111756 10.1038/ncb1685 (Pubitemid 351194053)
46. Azzalin C. M., Reichenbach P., Khoriauli L., Giulotto E., Lingner J., Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007 318 5851 798 801 2-s2.0-37349043972 10.1126/science.1147182 (Pubitemid 351411771)
47. Xu N., Donohoe M. E., Silva S. S., Lee J. T., Evidence that homologous X-chromosome pairing requires transcription and Ctcf protein. Nature Genetics 2007 39 11 1390 1396 2-s2.0-35649000946 10.1038/ng.2007.5 (Pubitemid 350035004)
48. Zhang L. F., Huynh K. D., Lee J. T., Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. Cell 2007 129 4 693 706 2-s2.0-34249006523 10.1016/j.cell.2007.03.036 (Pubitemid 46802377)
49. Amaral P. P., Dinger M. E., Mercer T. R., Mattick J. S., The eukaryotic genome as an RNA machine. Science 2008 319 5871 1787 1789 2-s2.0-41349116135 10.1126/science.1155472 (Pubitemid 351451554)
50. Formisano L., Noh K. M., Miyawaki T., Mashiko T., Bennett M. V. L., Zukin R. S., Ischemic insults promote epigenetic reprogramming of opioid receptor expression in hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 2007 104 10 4170 4175 2-s2.0-34247185756 10.1073/pnas.0611704104 (Pubitemid 47181597)
51. Sato F., Tsuchiya S., Meltzer S. J., Shimizu K., MicroRNAs and epigenetics. FEBS Journal 2011 278 10 1598 1609 2-s2.0-79955581917 10.1111/j.1742-4658.2011.08089.x
52. Dharap A., Bowen K., Place R., Li L. C., Vemuganti R., Transient focal ischemia induces extensive temporal changes in rat cerebral MicroRNAome. Journal of Cerebral Blood Flow and Metabolism 2009 29 4 675 687 2-s2.0-63949084047 10.1038/jcbfm.2008.157
53. Nicolas F. E., Pais H., Schwach F., Lindow M., Kauppinen S., Moulton V., Dalmay T., Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 2008 14 12 2513 2520 2-s2.0-57049089111 10.1261/rna.1221108
54. Jeyaseelan K., Lim K. Y., Armugam A., MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008 39 3 959 966 2-s2.0-41249102422 10.1161/STROKEAHA.107.500736 (Pubitemid 351619577)
55. Xin H., Li Y., Buller B., Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 2012 30 7 1556 1564
56. Zhao X., He X., Han X., Yu Y., Ye F., Chen Y., Hoang T., Xu X., Mi Q. S., Xin M., Wang F., Appel B., Lu Q. R., MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 2010 65 5 612 626 2-s2.0-77649166937 10.1016/j.neuron.2010.02.018
57. Mercer T. R., Dinger M. E., Mattick J. S., Long non-coding RNAs: insights into functions. Nature Reviews Genetics 2009 10 3 155 159 2-s2.0-60349120914 10.1038/nrg2521
58. Mercer T. R., Dinger M. E., Mariani J., Kosik K. S., Mehler M. F., Mattick J. S., Noncoding RNAs in long-term memory formation. Neuroscientist 2008 14 5 434 445 2-s2.0-52449130135 10.1177/1073858408319187
59. Rashidian J., Iyirhiaro G., Aleyasin H., Rios M., Vincent I., Callaghan S., Bland R. J., Slack R. S., During M. J., Park D. S., Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2005 102 39 14080 14085 2-s2.0-25444460165 10.1073/pnas.0500099102 (Pubitemid 41377706)
60. Ishii N., Ozaki K., Sato H., Mizuno H., Susumu Saito, Takahashi A., Miyamoto Y., Ikegawa S., Kamatani N., Hori M., Satoshi Saito, Nakamura Y., Tanaka T., Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. Journal of Human Genetics 2006 51 12 1087 1099 2-s2.0-33751277900 10.1007/s10038-006-0070-9 (Pubitemid 44800728)
61. Qureshi I. A., Mehler M. F., The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Archives of Neurology 2010 67 12 1435 1441 2-s2.0-78650112000 10.1001/archneurol.2010.300
62. Peng P. L., Zhong X., Tu W., Soundarapandian M. M., Molner P., Zhu D., Lau L., Liu S., Liu F., Lu Y., ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron 2006 49 5 719 733 2-s2.0-33344477023 10.1016/j.neuron.2006.01.025 (Pubitemid 43290131)
63. Blow M. J., Grocock R. J., van Dongen S., Enright A. J., Dicks E., Futreal P. A., Wooster R., Stratton M. R., RNA editing of human microRNAs. Genome Biology 2006 7 4, article R27 2-s2.0-33745053086 10.1186/gb-2006-7-4-r27 (Pubitemid 43871875)
64. Kawahara Y., Zinshteyn B., Chendrimada T. P., Shiekhattar R., Nishikura K., RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Reports 2007 8 8 763 769 2-s2.0-34547629436 10.1038/sj.embor. 7401011 (Pubitemid 47202456)
65. Shani V., Bromberg Y., Sperling O., Zoref-Shani E., Involvement of Src tyrosine kinases (SFKs) and of focal adhesion kinase (FAK) in the injurious mechanism in rat primary neuronal cultures exposed to chemical ischemia. Journal of Molecular Neuroscience 2009 37 1 50 59 2-s2.0-62649161970 10.1007/s12031-008-9113-3
66. Selvamani A., Sathyan P., Miranda R., Sohrabji F., An antagomir to MicroRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS ONE 7 2 e32662 10. 1371/journal.pone. 0032662
67. Conticello S. G., The AID/APOBEC family of nucleic acid mutators. Genome Biology 2008 9 6, article 229 2-s2.0-50349093233 10.1186/gb-2008-9-6-229
68. Silander K., Alanne M., Kristiansson K., Saarela O., Ripatti S., Auro K., Karvanen J., Kulathinal S., Niemelä M., Elionen P., Vartiainen E., Jousilahti P., Saarela J., Kuulasmaa K., Evans A., Perola M., Salomaa V., Peltonen L., Gender differences in genetic risk profiles for cardiovascular disease. PLoS ONE 2008 3 10 2-s2.0-56349150149 10.1371/journal.pone.0003615 e3615
69. Wang Y. J., Wang X., Zhang H., Zhou L., Liu S., Kolson D. L., Song L., Ye L., Ho W. Z., Expression and regulation of antiviral protein APOBEC3G in human neuronal cells. Journal of Neuroimmunology 2009 206 1-2 14 21 2-s2.0-58149468597 10.1016/j.jneuroim.2008.10.003
70. Mattick J. S., Mehler M. F., RNA editing, DNA recoding and the evolution of human cognition. Trends in Neurosciences 2008 31 5 227 233 2-s2.0-43049105810 10.1016/j.tins.2008.02.003
71. Watson J. A., Watson C. J., Mccann A., Baugh J., Epigenetics, the epicenter of the hypoxic response. Epigenetics 2010 5 4 293 296 2-s2.0-77954661616 10.4161/epi.5.4.11684
72. Sang N., Chen S., Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors. Journal of Biomedicine and Biotechnology 2011 2011 2-s2.0-79251576774 10.1155/2011/197946 197946
73. Biswas S., Roy S., Banerjee J., Hussain S. R. A., Khanna S., Meenakshisundaram G., Kuppusamy P., Friedman A., Sen C. K., Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proceedings of the National Academy of Sciences of the United States of America 2010 107 15 6976 6981 2-s2.0-77951043486 10.1073/pnas.1001653107
74. Chan S. Y., Loscalzo J., MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010 9 6 1072 1083 2-s2.0-77953483108
75. Saugstad J. A., MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. Journal of Cerebral Blood Flow & Metabolism 2010 30 1564 1576
76. Hsieh C. H., Jeng J. C., Jeng S. F., Wu C. J., Lu T. H., Liliang P. C., MicroRNA profiling in ischemic injury of the gracilis muscle in rats. BMC Musculoskeletal Disorders 2010 11, article 123
77. Stowell C., Wang L., Arbogast B., Lan J. Q., Cioffi G. A., Burgoyne C. F., Zhou A., Retinal proteomic changes under different ischemic conditions-Implication of an epigenetic regulatory mechanism. International Journal of Physiology, Pathophysiology and Pharmacology 2010 2 2 148 160 2-s2.0-77954740474
78. Fasanaro P., Greco S., Ivan M., Capogrossi M. C., Martelli F., microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacology and Therapeutics 2010 125 1 92 104 2-s2.0-72049101201 10.1016/j.pharmthera.2009.10. 003
79. Yin C., Salloum F. N., Kukreja R. C., A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circulation Research 2009 104 5 572 575 2-s2.0-63649126549 10.1161/CIRCRESAHA.108.193250
80. Kim H. W., Haider H. K., Jiang S., Ashraf M., Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. Journal of Biological Chemistry 2009 284 48 33161 33168 2-s2.0-70450240736 10.1074/jbc.M109.020925
81. Lusardi T. A., Farr C. D., Faulkner C. L., Pignataro G., Yang T., Lan J., Simon R. P., Saugstad J. A., Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. Journal of Cerebral Blood Flow and Metabolism 2010 30 4 744 756 2-s2.0-77950517876 10.1038/jcbfm.2009.253
82. Cheng Y., Zhu P., Yang J., Liu X., Dong S., Wang X., Chun B., Zhuang J., Zhang C., Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovascular Research 2010 87 3 431 439 2-s2.0-77954797933 10.1093/cvr/cvq082
83. Jose A. M., Hunter C. P., Transport of sequence-specific RNA interference information between cells. Annual Review of Genetics 2007 41 305 330 2-s2.0-42549118348 10.1146/annurev.genet.41.110306.130216
84. Faraco G., Pancani T., Formentini L., Mascagni P., Fossati G., Leoni F., Moroni F., Chiarugi A., Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Molecular Pharmacology 2006 70 6 1876 1884 2-s2.0-33751120697 10.1124/mol.106.027912 (Pubitemid 44771903)
85. Takami Y., Nakagami H., Morishita R., Katsuya T., Cui T. X., Ichikawa T., Saito Y., Hayashi H., Kikuchi Y., Nishikawa T., Baba Y., Yasuda O., Rakugi H., Ogihara T., Kaneda Y., Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF- B activation. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 10 2184 2190 2-s2.0-35148859639 10.1161/ATVBAHA.107.142505 (Pubitemid 350287248)
86. Setsuie R., Wada K., The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochemistry International 2007 51 2-4 105 111 2-s2.0-34547535639 10.1016/j.neuint.2007.05.007 (Pubitemid 47179898)
87. Lin Y. C., Lin J. H., Chou C. W., Chang Y. F., Yeh S. H., Chen C. C., Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Research 2008 68 7 2375 2383 2-s2.0-42049088710 10.1158/0008-5472.CAN-07-5807 (Pubitemid 351521812)
88. Dharap A., Bowen K., Place R., Li L. C., Vemuganti R., Transient focal ischemia induces extensive temporal changes in rat cerebral MicroRNAome. Journal of Cerebral Blood Flow and Metabolism 2009 29 4 675 687 2-s2.0-63949084047 10.1038/jcbfm.2008.157
89. Yin K. J., Deng Z., Huang H., Hamblin M., Xie C., Zhang J., Chen Y. E., miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiology of Disease 2010 38 1 17 26 2-s2.0-77549088509 10.1016/j.nbd.2009.12.021
90. Saugstad J. A., MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. Journal of Cerebral Blood Flow and Metabolism 2010 30 9 1564 1576 2-s2.0-77956263239 10.1038/jcbfm.2010.101
91. Sharp F. R., Jickling G. C., Stamova B., Tian Y., Zhan X., Liu D., Kuczynski B., Cox C. D., Ander B. P., Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. Journal of Cerebral Blood Flow and Metabolism 2011 31 1513 1531 10.1038/jcbfm.2011.45 2-s2.0-79955115339 10.1038/jcbfm.2011.45
92. Landry P., Plante I., Ouellet D. L., Perron M. P., Rousseau G., Provost P., Existence of a microRNA pathway in anucleate platelets. Nature Structural and Molecular Biology 2009 16 9 961 966 2-s2.0-69949124465 10.1038/nsmb.1651
93. Jeyaseelan K., Lim K. Y., Armugam A., MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008 39 3 959 966 2-s2.0-41249102422 10.1161/STROKEAHA.107.500736 (Pubitemid 351619577)
94. Tan K. S., Armugam A., Sepramaniam S., Lim K. Y., Setyowati K. D., Wang C. W., Jeyaseelan K., Expression profile of microRNAs in young stroke patients. PLoS ONE 2009 4 11 2-s2.0-70449377174 10.1371/journal.pone.0007689 e7689
95. Liu D. Z., Tian Y., Ander B. P., Xu H., Stamova B. S., Zhan X., Turner R. J., Jickling G., Sharp F. R., Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. Journal of Cerebral Blood Flow and Metabolism 2010 30 1 92 101 2-s2.0-73949091031 10.1038/jcbfm.2009.186
96. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., Dean D. B., Zhang C., MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circulation Research 2007 100 11 1579 1588 2-s2.0-34250172419 10.1161/CIRCRESAHA.106.141986 (Pubitemid 46897261)
97. Zhang Z., Yang X., Zhang S., Ma X., Kong J., BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia. Stroke 2007 38 5 1606 1613 2-s2.0-34247572412 10.1161/STROKEAHA.106.475129 (Pubitemid 46684181)
98. Miyawaki T., Ofengeim D., Noh K. M., Latuszek-Barrantes A., Hemmings B. A., Follenzi A., Zukin R. S., The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death. Nature Neuroscience 2009 12 5 618 626 2-s2.0-67349248703 10.1038/nn.2299
99. Wood M., Yin H., McClorey G., Modulating the expression of disease genes with RNA-based therapy. PLoS Genetics 2007 3 6 e109 2-s2.0-38449110627 10.1371/journal.pgen.0030109 (Pubitemid 47015847)
100. Yan A. C., Levy M., Aptamers and aptamer targeted delivery. RNA Biology 2009 6 3 316 320 2-s2.0-79957872986
101. Gyorgy A. B., Szemes M., De Juan Romero C., Tarabykin V., Agoston D. V., SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons. European Journal of Neuroscience 2008 27 4 865 873 2-s2.0-38749103401 10.1111/j.1460-9568.2008.06061.x (Pubitemid 351365172)
102. Mercer T. R., Dinger M. E., Sunkin S. M., Mehler M. F., Mattick J. S., Specific expression of long noncoding RNAs in the mouse brain. Proceedings of the National Academy of Sciences of the United States of America 2008 105 2 716 721 2-s2.0-38649114329 10.1073/pnas.0706729105 (Pubitemid 351171774)
103. Qureshi I. A., Mehler M. F., Regulation of non-coding RNA networks in the nervous system-What's the REST of the story? Neuroscience Letters 2009 466 2 73 80 2-s2.0-70350126990 10.1016/j.neulet.2009.07.093
104. Calderone A., Jover T., Noh K. M., Tanaka H., Yokota H., Lin Y., Grooms S. Y., Regis R., Bennett M. V. L., Zukin R. S., Ischemic insults derepress the gene silencer REST in neurons destined to die. Journal of Neuroscience 2003 23 6 2112 2121 2-s2.0-0037444555 (Pubitemid 36368899)
105. Formisano L., Noh K. M., Miyawaki T., Mashiko T., Bennett M. V., Zukin R. S., Ischemic insults promote epigenetic reprogramming of opioid receptor expression in hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 2007 104 10 4170 4175 (Pubitemid 47181597)
106. Shan G., Li Y., Zhang J., Li W., Szulwach K. E., Duan R., Faghihi M. A., Khalil A. M., Lu L., Paroo Z., Chan A. W. S., Shi Z., Liu Q., Wahlestedt C., He C., Jin P., A small molecule enhances RNA interference and promotes microRNA processing. Nature Biotechnology 2008 26 8 933 940 2-s2.0-49449096792 10.1038/nbt.1481
107. Mansfield K. D., Keene J. D., The ribonome: a dominant force in co-ordinating gene expression. Biology of the Cell 2009 101 3 169 181 2-s2.0-60049097909 10.1042/BC20080055
108. DeGracia D. J., Jamison J. T., Szymanski J. J., Lewis M. K., Translation arrest and ribonomics in post-ischemic brain: layers and layers of players. Journal of Neurochemistry 2008 106 6 2288 2301 2-s2.0-50849101356 10.1111/j.1471-4159.2008.05561.x
109. Dinger M. E., Mercer T. R., Mattick J. S., RNAs as extracellular signaling molecules. Journal of Molecular Endocrinology 2008 40 3-4 151 159 2-s2.0-42549112125 10.1677/JME-07-0160 (Pubitemid 351586824)
110. Smalheiser N. R., Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biology Direct 2007 2, article 35 2-s2.0-38949191397 10.1186/1745-6150-2-35 (Pubitemid 351210952)
111. Liu H., Mulholland N., Fu H., Zhao K., Cooperative activity of BRG1 and Z-DNA formation in chromatin remodeling. Molecular and Cellular Biology 2006 26 7 2550 2559 2-s2.0-33645228949 10.1128/MCB.26.7.2550-2559.2006
112. Wang G., Vasquez K. M., Z-DNA, an active element in the genome. Frontiers in Bioscience 2007 12 12 4424 4438 2-s2.0-34347205992 10.2741/2399